Amneal Pharmaceuticals Overview

  • Founded
  • 2002
Founded
  • Status
  • Public
  • Employees
  • 6,000
Employees
  • Stock Symbol
  • AMRX
Stock Symbol
  • Investments
  • 15
  • Share Price
  • $4.95
  • (As of Friday Closing)

Amneal Pharmaceuticals General Information

Description

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products and Specialty products. Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. It generates a majority of its revenue from the Generic business segment.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Distributors (Healthcare)
Drug Discovery
Stock Exchange
NYS
Primary Office
  • 400 Crossing Boulevard
  • 3rd Floor
  • Bridgewater, NJ 08807
  • United States
+1 (908) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Amneal Pharmaceuticals Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.95 $4.83 $2.40 - $6.18 $731M 148M 1.5M $0.62

Amneal Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 3,413,788 3,413,788 3,443,817 4,846,406
Revenue 1,992,523 1,992,523 1,626,373 1,662,991
EBITDA 345,605 345,605 155,198 78,252
Net Income 91,059 91,059 (361,917) (169,726)
Total Assets 4,006,033 4,006,033 3,665,890 4,352,736
Total Debt 2,943,126 2,943,126 2,769,936 2,691,396
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Amneal Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Amneal Pharmaceuticals‘s full profile, request access.

Request a free trial

Amneal Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Produ
Pharmaceuticals
Bridgewater, NJ
6,000 As of 2020
00.000
000000 - 000 00.000

0000000

mco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volup
000000000000000
Trevose, PA
000 As of 0000
000000000

00000 00

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatu
000000000000000
Woodcliff Lake, NJ
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Amneal Pharmaceuticals Competitors (22)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lannett Company Corporation Trevose, PA 000 000000000
00000 000000000000 Formerly VC-backed Woodcliff Lake, NJ 000 00000 00000000000 00000
0000 0000000000000 Corporate Backed or Acquired Haifa Bay, Israel 0000 0000 00000000000
00000 Failed Transaction (M&A) Hafnarfjordur, Iceland 000 000000000000
000 00000000000000 Formerly PE-Backed Ramapo, NY 0000 000.00 000000&0 000.00
You’re viewing 5 of 22 competitors. Get the full list »

Amneal Pharmaceuticals Executive Team (36)

Name Title Board Seat Contact Info
Chintu Patel Chief Executive Officer & Founder
Chirag Patel Chief Executive Officer & Founder
Janos Vaczi President, European Operations
Kanu Patel Co-Founder, Chairman and Managing Director
Bryan Sommese Director - Global Intellectual Property
You’re viewing 5 of 36 executive team members. Get the full list »

Amneal Pharmaceuticals Board Members (9)

Name Representing Role Since
00000 00000000 0000 Amneal Pharmaceuticals Board Member 000 0000
0. 00000 Self Board Member 000 0000
0000 00000 Amneal Pharmaceuticals Co-Founder, Chairman and Managing Director 000 0000
0000 0000000 Self Chairman & Board Member 000 0000
000000 00000 Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Amneal Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Amneal Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Amneal Pharmaceuticals‘s full profile, request access.

Request a free trial

Amneal Pharmaceuticals Investments & Acquisitions (15)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000000 11-Jan-2021 000000000000000000 00000 Drug Discovery 000000 00000
000000 31-Jan-2020 000000000000000000 00000 Pharmaceuticals 000000 00000
000000 00000000000 07-May-2018 000000000000000000 00000 Distributors (Healthcare)
00000 000000000000 04-May-2018 0000000000 Pharmaceuticals 000000 00000
Actavis Australia 01-May-2015 Merger/Acquisition 00.000 Pharmaceuticals 000000 00000
You’re viewing 5 of 15 investments and acquisitions. Get the full list »

Amneal Pharmaceuticals Subsidiaries (2)

Company Name Industry Location Founded
Gemini Laboratories Distributors (Healthcare) Bridgewater, NJ 2013
000000 Pharmaceuticals Pulaski, TN 0000
To view Amneal Pharmaceuticals’s complete subsidiaries history, request access »

Amneal Pharmaceuticals Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 000000 01-Jun-2013 0000000000 Completed
  • 3 buyers
To view Amneal Pharmaceuticals’s complete exits history, request access »